We are live on ! Find out more
FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

25 hedge funds and large institutions have $4.35M invested in F-star Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more capital invested

Capital invested by funds: $2.77M → $4.35M (+$1.58M)

11% less funds holding

Funds holding: 28 → 25 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

70% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 10

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
10
Closed
5
Calls
$294K
Puts
–
Net Calls
+$294K
Net Calls Change
+$108K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$196K
2
ECM
ExodusPoint Capital Management
New York
+$23.1K
3
TRCT
Tower Research Capital (TRC)
New York
+$11.3K
4
Northern Trust
Northern Trust
Illinois
+$6.88K
5
Wells Fargo
Wells Fargo
California
+$6

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$68.3K
2
BlackRock
BlackRock
New York
-$48.4K
3
PCM
Parsons Capital Management
Rhode Island
-$33.7K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$24K
5
BI
BVF Inc
California
-$15.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
– -$11K -3,047 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$10K -2,641 Closed
Victory Capital Management
28
Victory Capital Management
Texas
– -$6K -1,359 Closed
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
– -$2K -500 Closed
Wells Fargo
30
Wells Fargo
California
– +$6 +1 +5%
1
2

FSTX Hedge Fund Activity: Q2 2020 in Review

25 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q2 2020, worth a combined $4.35M — up 57% from $2.77M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of FSTX and 2 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $196K. The largest seller was JP Morgan Chase, cutting an estimated $68.3K.

  • 25 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q2 2020, down from 28 in Q1 2020.
  • Funds reported $4.35M of F-star Therapeutics, Inc. Common Stock stock for Q2 2020, up 57% quarter-over-quarter.
  • 2 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q2 2020 and 5 closed out, a net change of -3 holders.
  • The largest F-star Therapeutics, Inc. Common Stock buyer in Q2 2020 was Renaissance Technologies, an estimated $196K added.
  • The largest F-star Therapeutics, Inc. Common Stock seller in Q2 2020 was JP Morgan Chase, an estimated $68.3K sold.

Based on aggregated 13F filings for Q2 2020.